Birds Eye View Technical Analysis forPacific Biosciences of California, Inc. (NASDAQ:PACB)

77

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Pacific Biosciences of California, Inc. (NASDAQ:PACB) for the period of 9-Day stands at 11.22% while the stochastic %D for the same period stands at 7.34%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Pacific Biosciences of California, Inc. (NASDAQ:PACB) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Pacific Biosciences of California, Inc. (NASDAQ:PACB) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Pacific Biosciences of California, Inc. (NASDAQ:PACB)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company’s technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.

Previous Day Activity Analysis

On the last trading day, Pacific Biosciences of California, Inc. (NASDAQ:PACB) opened the session at $4.56 and after going down -1.75% closed at $4.5. The stock lost -0.06 points in the last trade.

Pacific Biosciences of California, Inc. (NASDAQ:PACB)’s stock fluctuated in the range of $4.40 and $4.56 during the previous active session. Pacific Biosciences of California, Inc. (NASDAQ:PACB) traded with the volume of 730068 with average volume of 988.99 Million. The stock has MEDIUM volatility on the last trading session.

Currently the Beta for the company remains at 1.9 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.22 and 38.88 respectively.

Currently the Insider Ownership of the shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) is at 2.4% and the shares outstanding are 115.08 Million.

Important Ratio Analysis

Some important ratios to consider here for Pacific Biosciences of California, Inc. (NASDAQ:PACB) are discussed below:

Dividend yield of Pacific Biosciences of California, Inc. (NASDAQ:PACB) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 5.41 and 3.78 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 5.05 and 0 correspondingly.

The Quick Ratio of Pacific Biosciences of California, Inc. (NASDAQ:PACB) stands at 3.2 while the Current Ratio depicts the value of 3.7.

Return on Assets ROA of Pacific Biosciences of California, Inc. (NASDAQ:PACB) is at -57.1% whereas, Return on Equity ROE and Return of Investment ROI of Pacific Biosciences of California, Inc. (NASDAQ:PACB) stand at -93.3% and -70.7% respectively.

Stock Performance Analysis

The stock performance of Pacific Biosciences of California, Inc. (NASDAQ:PACB) on the basis of 5 day trade show the dip of -3.02% whereas, the monthly performance of the stock shows decrease of -16.04%.

The quarterly performance of the stock remained in green zone with the value of 34.73% while six month performance of the shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) remained bearish with the count of -5.26%.

The yearly and YTD performance of Pacific Biosciences of California, Inc. (NASDAQ:PACB) remained mix at -47.06% and 18.42% respectively.